Grape King Bio Ltd
TWSE:1707
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Grape King Bio Ltd
Free Cash Flow
Grape King Bio Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Grape King Bio Ltd
TWSE:1707
|
Free Cash Flow
NT$1.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Maxigen Biotech Inc
TWSE:1783
|
Free Cash Flow
NT$223m
|
CAGR 3-Years
0%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Maywufa Co Ltd
TWSE:1731
|
Free Cash Flow
NT$203.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
3%
|
|
|
Chlitina Holding Ltd
TWSE:4137
|
Free Cash Flow
NT$555.3m
|
CAGR 3-Years
36%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
1%
|
|
Grape King Bio Ltd
Glance View
Grape King Bio Ltd. engages in the production and sale of pharmaceutical preparations, patent medicine, liquid tonics, drinks, and healthy food. The company is headquartered in Taoyuan, Taoyuan. The firm operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The firm operates in Taiwan, mainland China and other markets.
See Also
What is Grape King Bio Ltd's Free Cash Flow?
Free Cash Flow
1.7B
TWD
Based on the financial report for Dec 31, 2025, Grape King Bio Ltd's Free Cash Flow amounts to 1.7B TWD.
What is Grape King Bio Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
3%
Over the last year, the Free Cash Flow growth was 40%. The average annual Free Cash Flow growth rates for Grape King Bio Ltd have been -12% over the past three years , 3% over the past five years .
